INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Why Use Scorecards To Make Vendor Selection Decisions
Scorecards enable structured, unbiased vendor selection by transforming complex clinical trial decisions into transparent, data-driven evaluations — ensuring operational excellence and regulatory compliance.
-
Bottling Solutions
Explore a bottling solution that is meticulously engineered to adhere to the most stringent pharmaceutical standards, which guarantees that each product is crafted with unparalleled quality and precision.
-
Equitable Access To Clinical Trials & The Trial Modernization Act
How are the Equitable Access to Clinical Trials (EACT) initiative and Clinical Trial Modernization Act (CTMA) being used to improve clinical trial inclusivity by addressing financial barriers?
-
In A Time Of Uncertainty, Reliable Partners Are Vital To Researchers
By selecting stable and proven solution providers, uncover how researchers can ensure the uninterrupted continuity of their trials and seamlessly launch new studies.
-
CRO Uses CRIO eSource To Double Monitoring Productivity1/31/2025
Examine the transformative impact of eSource technology on monitoring productivity during a global Phase 3 trial conducted by a Contract Research Organization (CRO) amid the COVID-19 pandemic.
-
What Sponsors Must Know To Safeguard Ocular Endpoints7/7/2025
Explore the necessity of incorporating imaging methodologies early in the trial design to improve data quality and overall trial efficiency.
-
DCTs And Community-Based Research Execution And Compliance5/28/2025
The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.
-
Improving ISR Success Rates In Bioanalysis Of Small Molecule Drugs1/23/2025
Leveraging incurred sample reanalysis (ISR) in your quality control helps your team mitigate risks, establish regulatory compliance, and instill confidence in your pharmacokinetic modeling.
-
Targeted Protein Degraders: Transforming Oral Therapeutics8/11/2025
CDMOs play a critical role in TPD development by offering specialized infrastructure and analytical capabilities to support the transition from preclinical research to clinical supply and commercialization.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Learn more about the Global ESG Program and how the continued development of sustainability initiatives contributes to positive impact on the environment and the communities in which we operate.
-
Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes, and relatively high costs.
-
Global Strategies to Align Your Goals With Regulatory Requirements
Ergomed’s regulatory consultancy services are guided by a team of seasoned consultants, each bringing a wealth of experience from regulatory agencies and in-house roles. This expertise ensures a proactive and flexible solution tailored to your project’s unique needs and timelines, instilling confidence in our services.
-
At IQVIA Biotech, our extensive oncology expertise, coupled with the ability to leverage IQVIA’s vast data, technology, and analytics resources, creates a clinical development partner perfect for you.
-
The biggest issues for faltering trials? Incomplete planning and enrollment issues can explode into big problems if not addressed early enough. Biorasi offers a no-commitment, no-charge, fast consulting assessment that will identify and correct these issues in your study early – before they grow too big to manage.